维普中文期刊产品整合服务
37篇 您的检索式:作者名="Borgiani"
    题名 作者 年代 出处 被引量
1Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine?显示文摘Every disease treatment is ideally finalized to prevent symptom occurrence,to stop or slow down the progression of disease,to alleviate complications already present and consequently to improve the quality of life for each patient.Unfortunately,in Parkinson’s disease(PD)a treatment able to completely cure the disease is not so far available.Indeed,until now,the current therapies only allow to control the disease symptoms,Cinzia Ciccacci Paola Borgiani 2019Neural Regeneration Research2019,14,1:2
2CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing vari- ability in the Italian population 显示文摘Borgiani P Ciccacci C Forte V 2009Pharmaeogenomies2009,10,2:1
3Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 显示文摘Borgiani P Ci ccacci C FORTE V 2007Pharmacogenomics2007,8,11:1
4A family study of asymptomatic small bowel Crohn’s disease显示文摘Livia Biancone Emma Calabrese Carmelina Petruzziello Alessandra Capanna Francesca Zorzi Sara Onali Giovanna Condino Elisabetta Lolli Cinzia Ciccacci Paola Borgiani Francesco Pallone 2013Digestive and Liver Disease2013,,:1
5CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 显示文摘Borgiani P Ciccacci C Forte V 2009Pharmacogenomics2009,10,2:1
6Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 ( OLR1 ) gene in patients with acute myocardial infarction 显示文摘Mango R Glementi F Borgiani P 2003J Med Genet2003,40,12:1
7Association of single oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction 显示文摘Mango R Clementi F Borgiani nucleotide polymorphisms in the P 2003J Med Genet2003,40,12:1
8Exclusion of CARD15/ NOD2 as a candidate susceptibility gene to psoriasis in the Italian population显示文摘Borgiani P Vallo L D'Apice MR 2002Eur J Dermatol2002,12,6:1
9CYP4F2 genetic variant (rs210 8622) significantly contributes to warfarin dosing variability in the Italian population显示文摘Borgiani P Ciccacci C Forte V 2009Pharmacogenomics2009,10,2:1
10Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial显示文摘Mango R Clementi F Borgiani P 2003J Med Genet2003,40,12:1
11CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population显示文摘BORGIANI P CICCACCI C FORTE V 2009Pharmacogenomics2009,10,2:1
12Role of genetics in prevention of coronary atherosclerosis 显示文摘Novelli G Borgiani P Giardina E 2003Curr Opin Cardiol2003,18,5:1
13Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians显示文摘BORGIANI P CICCACCI C FORTE V 2007Pharmacogenomics2007,8,11:1
14Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 ( OLR1 ) gene in patients with acute myocardial infarction 显示文摘Mango R Clementi F Borgiani P 2003J Med Genet2003,40,12:1
15Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLRI) gene in patients with acute myocardial infarction显示文摘Mango R Clementi F Borgiani P 2003J Med Genet2003,40,12:1
16Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction 显示文摘MANGO R CLEMENTI F BORGIANI P 2003J Med Genet2003,40,12:1
17CYP4F2 genetic variant (rs2108622)significantly contributes to warfarin dosing variability in the Italian population显示文摘Borgiani P Ciccacci C Forte V 2009Pharmacogenomics2009,10,2:1
18Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction显示文摘Mango R Clementi F Borgiani P 0,,:1
19High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase显示文摘Lee M Y Borgiani P Johansson I 0,,41:1
20CYP4F2 ge- netic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 显示文摘Borgiani P Ciccacci C Forte V 2009Pharmacogenornies2009,10,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费